Vaxxel (private company)
See something wrong or missing? Let us know
Offices:Lyon
Business model:B2B
Vaxxel is a French biotech company that develops the first intranasal live attenuated and multivalent viral vaccine against HMPV and HRSV for paediatric and elderly indications from an HMPV-derived vaccine platform.
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 1.32M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Vaxxel
Name | Criteria | |
---|---|---|
![]() |
Pharmedigroup
70%
|
|
![]() |
Pila Pharma
70%
|
|
![]() |
PEP-Therapy
70%
|
|
![]() |
Nanolyze
70%
|
|
![]() |
Mytos
70%
|
|
![]() |
Nanoligent
70%
|
|
![]() |
Beckley Psytech
65%
|
|
![]() |
Cinclus Pharma
65%
|
|
![]() |
iCellate
65%
|
|
![]() |
Octarine Bio
65%
|
|